Cargando…
Early Investigational and Experimental Therapeutics for the Treatment of Hypertriglyceridemia
Hypertriglyceridemia has been identified as a risk factor for cardiovascular disease and acute pancreatitis. To date, there are only few drug classes targeting triglyceride levels such as fibrates and ω-3 fatty acids. These agents are at times insufficient to address very high triglycerides and the...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874974/ https://www.ncbi.nlm.nih.gov/pubmed/35200696 http://dx.doi.org/10.3390/jcdd9020042 |